Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression
Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This is a single center phase I / II clinical trial. Randomized, blind and positive drug
parallel control were used to evaluate the safety and effectiveness of dental pulp
mesenchymal cell injection in the treatment of depression 8 weeks after administration